Medicines consultation

What the NHS is doing nationally - medicines consultations 

From 21 July – 21 October 2017 NHS England, the organisation that leads the NHS, ran a public consultation on proposals to no longer routinely prescribe 18 ‘low value’ medicines that are available by a prescription only or over the counter. Follow this link to read BHR CCGs response to the consultation.

After reviewing the responses to its consultation, NHS England recommended that these 18 medicines should no longer be routinely prescribed. On 30 November 2017 NHS England’s Board approved the recommendations and has since issued national guidance to help CCGs when they decide which of these medicines to fund and prescribe locally. We are reviewing this guidance and how it might affect local prescribing.

During its consultation, NHS England also sought views on potentially restricting the routine prescribing of medicines that are available over the counter for the treatment of minor conditions or those which are best treated via self-care. The feedback received was broadly supportive and so it plans to consult on proposals related to a number of conditions and treatments in 2018. You can find more information at:

Note: Locally we have already consulted on some of these medicines and has decided not to fund them. Once the results of this national consultation are known, later in 2018, we will assess the new guidance and how it might affect its local prescribing.

Page last updated 24 September 2019